Isabelle Melki is a paediatric rheumatologist, MD, PhD, with a special interest in type I interferonopathies, interferon pathways, autoinflammatory diseases, juvenile dermatomyositis and juvenile systemic lupus erythematosous, especially with neuropsychiatric features. She is currently the president of SOFREMIP (Société francophone d'étude de la rhumatologie et des maladies inflammatoires en pédiatrie) and working in the French FAI2R network for rare autoimmune and autoinflammatory diseases, with the purpose to reduce time to diagnosis delay.